A carregar...
Serum Exosomal EphA2 is a Prognostic Biomarker in Patients with Pancreatic Cancer
BACKGROUND: Pancreatic cancer (PC) is one of the worst prognoses amongst all malignant diseases. It is therefore of great significance to identify biomarkers with predictive clinical value for the prognosis and recurrence of PC. METHODS: In our study, enzyme-linked immunosorbent assays (ELISA) were...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8112875/ https://ncbi.nlm.nih.gov/pubmed/33994808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S304719 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|